Appeared in the Toronto Star on August 19, 2012 as Public Safety Shuffle Could Allow for an Internet Surveillance Restart Sometime in the next few weeks, Public Safety Minister Vic Toews is expected to be appointed to the Manitoba Court of Appeal. The Toews appointment is among the worst kept […]
Articles by: Michael Geist
Why the End of Access Copyright K-12 Licensing for Is Not The End of Payment for Educational Copying
In light of the decisions and recent copyright law reforms, K-12 schools are likely to conclude that they do not need an Access Copyright licence. While the collective and its supporters will react by claiming that this will greatly harm Canadian publishers and authors, the reality is that schools have permission to reproduce the overwhelming majority of materials without Access Copyright or fair dealing.
Access Copyright has argued that the case only focused on 7% of copies, but the truth is that it involved an even smaller amount. The 7% figure stems from the copies for which Access Copyright seeks payment. In fact, the Access Copyright sponsored study that lies at the heart of the K-12 case found that schools already had permission to reproduce 88% of all books, periodicals, and newspapers without even conducting a copyright analysis or turning to the Access Copyright licence.
If Bell-Astral Operated in the United States…
Embedded below is a graphical look at what a Bell-Astral combined entity might look like in the United States (courtesy of Telus). The level of media concentration is remarkable, cutting across all sectors in a way that no one does in the U.S.
Billions at Stake if Canada Caves on Drug Patent Demands
My weekly technology law column (Toronto Star version, homepage version) notes that Canadian negotiators recently advised that there remains a sharp divide over issues such as investment rules, financial services, and taxation. Given the ongoing European financial crisis, these issues are particularly sensitive and will raise questions about how much risk the government is willing to assume in order to strike a deal.
The most contentious issue, however, is likely to be the intellectual property chapter. The revelation that provisions from the Anti-Counterfeiting Trade Agreement may sneak their way into CETA generated widespread headlines throughout Europe last month with politicians and activists expressing exasperation at the clumsy attempt to secretly revive an agreement that was roundly rejected by the European Parliament.
The Canadian opposition to the chapter will come from European demands for patent reforms that could result in billions in additional health care costs due to higher pharmaceutical prices. The pharmaceutical demands are one Europe’s top priorities, but Canada has thus far refused to counter the EU proposals, creating a stalemate that has dragged on for years.
Billions at Stake if Canada Caves on Drug Patent Demands
Appeared in the Toronto Star on August 12, 2012 as Billions at Stake if Canada Caves on Drug Patent Demands The negotiations over a Canada – European Union trade agreement may be approaching the final stretch as both sides say they plan to wrap up the CETA talks by the […]







